Risk factors for mortality in patients with anti-NMDA receptor encephalitis
Authors:
- 27 December 2016
- journal article
- research article
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 136 (4) , 298-304
Abstract
Objective Anti‐N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis is a severe autoimmune disorder with a mortality of 5%‐7%, but few studies have focused on the predictors of death in this disease. In this study, we aim to investigate predictors and causes of death in patients with anti‐NMDAR encephalitis. Methods In this cohort study, patients with anti‐NMDAR encephalitis were enrolled at the West China Hospital of Sichuan University between June 2011 and October 2015. The outcomes of patients were evaluated by long‐term follow‐up. Cox regression analysis was used to assess the association between potential predictors and death. Results Altogether 96 patients were included in this study, and 11 died after median 24.5 (7‐57) months of follow‐up. The mortality of anti‐NMDAR encephalitis was 11.46%. Multivariate analysis results showed that Glasgow Coma Scale (GCS) score ≤8 at admission (HR=15.917, 95% CI=1.729‐146.562; P=.015), the number of complications (HR=7.772, 95% CI=1.944‐31.072; P=.004), and admission to an intensive care unit (HR=70.158, 95% CI=2.395‐2055.459; P=.014) were significantly associated with increased risk of mortality. Twelve patients received second‐line immunotherapy, and the cohort was relatively under‐treated compared with other studies. The main causes of death were severe pneumonia, multiple organ dysfunction syndrome, and refractory status epilepticus. Conclusion GCS score ≤8 at admission, number of complications, and admission to an intensive care unit are predictors of death. Management of complications may improve the prognosis of anti‐NMDAR encephalitis.Keywords
Funding Information
- National Natural Science Foundation of China (81420108014, 81571272)
This publication has 24 references indexed in Scilit:
- Predictors of outcome in acute encephalitisNeurology, 2013
- Immunopathology of autoantibody-associated encephalitides: clues for pathogenesisBrain, 2012
- The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocolBrain, 2011
- Anti-NMDA-Receptor Encephalitis: Case Report and Literature Review of an Under-Recognized ConditionJournal of General Internal Medicine, 2011
- Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitisThe Lancet Neurology, 2011
- N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexesBrain, 2010
- Cellular and Synaptic Mechanisms of Anti-NMDA Receptor EncephalitisThe Journal of Neuroscience, 2010
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 2008
- Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratomaAnnals of Neurology, 2007
- Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratomaAnnals of Neurology, 2005